| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Tyme Technologies Inc (NASDAQ: TYME)
TYME Technical Analysis
5
| As on 16th Sep 2022 TYME SHARE Price closed @ 0.31 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.01 & Strong Sell for SHORT-TERM with Stoploss of 1.46 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TYMESHARE Price
| Open | 0.29 | Change | Price | % |
| High | 0.32 | 1 Day | 0.02 | 6.90 |
| Low | 0.28 | 1 Week | 0.07 | 29.17 |
| Close | 0.31 | 1 Month | -0.02 | -6.06 |
| Volume | 2597928 | 1 Year | -1.45 | -82.39 |
| 52 Week High 1.87 | 52 Week Low 0.23 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| TYME Daily Charts |
TYME Intraday Charts |
Whats New @ Bazaartrend |
TYME Free Analysis |
|
|
TYME Important Levels Intraday
| RESISTANCE | 0.39 |
| RESISTANCE | 0.36 |
| RESISTANCE | 0.35 |
| RESISTANCE | 0.33 |
| SUPPORT | 0.29 |
| SUPPORT | 0.27 |
| SUPPORT | 0.26 |
| SUPPORT | 0.23 |
TYME Forecast April 2024
| 4th UP Forecast | 1.41 |
| 3rd UP Forecast | 1.06 |
| 2nd UP Forecast | 0.84 |
| 1st UP Forecast | 0.62 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | -0.22 |
| 3rd DOWN Forecast | -0.44 |
| 4th DOWN Forecast | -0.79 |
TYME Weekly Forecast
| 4th UP Forecast | 0.89 |
| 3rd UP Forecast | 0.70 |
| 2nd UP Forecast | 0.59 |
| 1st UP Forecast | 0.47 |
| 1st DOWN Forecast | 0.15 |
| 2nd DOWN Forecast | 0.03 |
| 3rd DOWN Forecast | -0.08 |
| 4th DOWN Forecast | -0.27 |
TYME Forecast2024
| 4th UP Forecast | 3.78 |
| 3rd UP Forecast | 2.67 |
| 2nd UP Forecast | 1.98 |
| 1st UP Forecast | 1.29 |
| 1st DOWN Forecast | -0.67 |
| 2nd DOWN Forecast | -1.36 |
| 3rd DOWN Forecast | -2.05 |
| 4th DOWN Forecast | -3.16 |
Tyme Technologies Inc ( NASDAQ USA Symbol : TYME )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TYME Business Profile
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead candidate is the SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, lung, breast, prostate, sarcoma, and lymphoma. The company also offers TYME-19, an oral synthetically produced member of the bile acid family, which is in preclinical stage for the treatment of COVID-19 and disease variants; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; NYU School of Medicine to examine multiple aspects of SM-88 mechanisms; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey. Address: 1 Pluckemin Way, Bedminster, NJ, United States, 07921
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service